Back to top
Top
U.S. flag

An official website of the United States government

Anti-depressant Medication Management

Compare Versions of: "Anti-depressant Medication Management"

The Compare function compares two years of the measure specifications found in the header of the measure's HTML. It does not include a comparison of any information in the body of the HTML, e.g., population criteria, Clinical Quality Language, or value sets.

Strikethrough text highlighted in red indicates information changed from the previous version. Text highlighted in green indicates information updated in the new eCQM version.

Compare 2024 version to

Table Options
Measure Information 2024 Performance Period
Title Anti-depressant Medication Management
CMS eCQM ID CMS128v12
CBE ID* Not Applicable
MIPS Quality ID 009
Measure Steward National Committee for Quality Assurance
Description

Percentage of patients 18 years of age and older who were treated with antidepressant medication, had a diagnosis of major depression, and who remained on an antidepressant medication treatment. Two rates are reported.

a. Percentage of patients who remained on an antidepressant...

Show more >
Measure Scoring Proportion measure
Measure Type Process
Stratification

None

Risk Adjustment

None

Rationale

Depression affects over 17 million adults in the U.S. (NIMH, 2021) and is estimated to affect nearly a quarter of adults in their lifetime (Burcusa & Iacono, 2007). Symptoms of depression include disturbances in appetite and sleep, anxiety, decreased concentration, and suicidal ideation...

Show more >
Clinical Recommendation Statement

American Psychological Association (2019):

- "For initial treatment of adult patients with depression, the panel recommends the following in the context of sharing decision-making with the patient when considering options:

1. That clinicians offer either psychotherapy or second-generation...

Show more >
Improvement Notation

Higher score indicates better quality

Definition

Intake Period: The 12-month window starting on May 1 of the year prior to the measurement period and ending on April 30 of the measurement period.

Index Prescription Start Date (IPSD): The date of the earliest prescription dispensing event for an antidepressant medication during the...

Show more >
Guidance

To identify new treatment episodes for major depression, there must be a 105-day negative medication history (a period during which the patient was not taking antidepressant medication) prior to the dispensing event associated with the IPSD.

This eCQM is a patient-based measure.

 

This...

Show more >
Initial Population

Patients 18 years of age and older as of April 30 of the measurement period who were dispensed antidepressant medications during the Intake Period, and were diagnosed with major depression 60 days prior to, or 60 days after the dispensing event and had a visit 60 days prior to, or 60...

Show more >
Denominator

Equals Initial Population

Denominator Exclusions

Patients who were actively on an antidepressant medication in the 105 days prior to the IPSD.

Exclude patients who are in hospice care for any part of the measurement period.

Numerator

Numerator 1: Patients who have received antidepressant medication for at least 84 days (12 weeks) of continuous treatment beginning on the IPSD through 114 days after the IPSD (115 total days).

Numerator 2: Patients who have received antidepressant medications for at least 180 days (6...

Show more >
Numerator Exclusions

Not Applicable

Denominator Exceptions

None

Telehealth Eligible Yes
Next Version
Previous Version

Header

  • Updated copyright.

    Measure Section: Copyright

    Source of Change: Annual Update

  • Updated the rationale based upon more recent literature and evidence to support the measure.

    Measure Section: Rationale

    Source of Change: Measure Lead

  • Updated the clinical recommendation statement based upon more recent literature and evidence to support the measure.

    Measure Section: Clinical Recommendation Statement

    Source of Change: Measure Lead

  • Updated references.

    Measure Section: Reference

    Source of Change: Measure Lead

Logic

  • Updated the version number of the Cumulative Medication Duration Library to v2.0.000.

    Measure Section: Definitions

    Source of Change: Annual Update

  • Added QDM datatype 'Diagnosis' to the Hospice.'Has Hospice Services' definition referencing a new value set containing SNOMED finding codes to provide an additional approach for identifying patients receiving hospice care.

    Measure Section: Definitions

    Source of Change: Measure Lead

  • Updated the version number of the Hospice Library to v5.0.000.

    Measure Section: Definitions

    Source of Change: Annual Update

  • Added a definition for Index Prescription Start Date (IPSD) to simplify and improve logic readability.

    Measure Section: Definitions

    Source of Change: Measure Lead

  • Updated the names of CQL definitions, functions, and/or aliases for clarification and to align with the CQL Style Guide.

    Measure Section: Definitions

    Source of Change: Standards/Technical Update

  • Added 'day of' specificity to hospice expressions for consistency.

    Measure Section: Definitions

    Source of Change: Measure Lead

  • Reversed priority of data elements used to calculate medication duration in function 'MedicationDispensedPeriod' to improve precision of calculation.

    Measure Section: Functions

    Source of Change: Measure Lead

  • Updated the 'CodeToDaily' function so that highest dose is calculated consistently.

    Measure Section: Functions

    Source of Change: Measure Lead

  • Updatedthe 'CumulativeDuration' function to account for null instances.

    Measure Section: Functions

    Source of Change: Measure Lead

  • Updated the version number of the Cumulative Medication Duration Library to v2.0.000.

    Measure Section: Functions

    Source of Change: Annual Update

  • Updated the version number of the Hospice Library to v5.0.000.

    Measure Section: Functions

    Source of Change: Annual Update

Value Set

The VSAC is the source of truth for the value set content, please visit the VSAC for downloads of current value sets.

  • Value set Antidepressant Medication (2.16.840.1.113883.3.464.1003.196.12.1213): Added 2 RxNorm codes (2591786, 2605950) based on review by technical experts, SMEs, and/or public feedback.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Hospice Care Ambulatory (2.16.840.1.113883.3.526.3.1584): Deleted 3 SNOMED CT codes (170935008, 170936009, 305911006) based on review by technical experts, SMEs, and/or public feedback.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Added value set Hospice Diagnosis (2.16.840.1.113883.3.464.1003.1165) based on review by technical experts, SMEs, and/or public feedback.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Hospice Encounter (2.16.840.1.113883.3.464.1003.1003): Added 2 SNOMED CT codes (305911006, 385765002) based on review by technical experts, SMEs, and/or public feedback.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Major Depression (2.16.840.1.113883.3.464.1003.105.12.1007): Added 1 SNOMED CT code (16264821000119108) based on review by technical experts, SMEs, and/or public feedback.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Online Assessments (2.16.840.1.113883.3.464.1003.101.12.1089): Added 4 CPT codes (98980, 98981, 99444, 99457) based on review by technical experts, SMEs, and/or public feedback. Added 3 HCPCS codes (G2250, G2251, G2252) based on review by technical experts, SMEs, and/or public feedback.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Payer (2.16.840.1.114222.4.11.3591): Added 5 SOP codes (1111, 1112, 142, 344, 141) based on review by technical experts, SMEs, and/or public feedback.

    Measure Section: Terminology

    Source of Change: Measure Lead

Last Updated: Jul 01, 2024